Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains
Author(s) -
Chao Wang,
Weiguo Shi,
Lifeng Cai,
Lu Lu,
Fei Yu,
Qian Wang,
Xifeng Jiang,
Xiaoyu Xu,
Kun Wang,
Liang Xu,
Shibo Jiang,
Keliang Liu
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku010
Subject(s) - enfuvirtide , human immunodeficiency virus (hiv) , biology , virology , heptad repeat , peptide , chemistry , gp41 , biochemistry , peptide sequence , immunology , antibody , epitope , gene
To develop new HIV-1 fusion inhibitors with improved antiviral activities and resistance profiles, we designed two categories of artificial peptides, each containing four heptad repeats (m4HR) conjugated with a pocket-specific small molecule (pssm) or pssm and cholesterol (chol), designated pssm-m4HR or pssm-m4HR-chol, respectively, and tested their anti-HIV-1 activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom